Current and Emerging Biomarkers in Immuno-Oncology
Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies.
sponsored by Bristol-Myers Squibb
This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.
Learning Objectives of Webinar
Gain better understanding of current and emerging I-O biomarkers and how they can be assessed in clinical practice
- Review of the immune system and cancer
- Current and Emerging predictive I-O biomarkers
- Biomarker testing practicalities